Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (25170)	7/14/2025 11:16:23 AM
From: #Breeze	Respond to of 26780

Not enough data.

To: Kirk © who wrote (25170)	7/20/2025 3:13:06 PM
From: Da Rookie	1 Recommendation Recommended By Kirk © Read Replies (1) \| Respond to of 26780

TNXP - Tonix pharmaceuticals didn’t have enough data earlier in the the year when it was around $10 today $47. They did simultaneous phase three studies and both had statically improvement and today waiting for Aug 15. The date FDA has to say ya or na.nthe IF approved new drug treats fibromyalgia with, this is important, a NON-OPIOD medication. If anyone. Interested the data is out there Disclosure, I’m in at 22, some profit at 34, now waiting for FDA ????